📰 Bd Team News
Page 2 - Bd Team News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bd Team. Real-time updates on events, politics, business and more.
September 20, 2023
DAHLIN is an award-winning architecture, planning, and interiors design firm with 170+ multi-cultural professionals located throughout the Western United States. We offer more than 45 years of experience building communities where we live and work, driven by the vision of creating places that...
September 20, 2023
DAHLIN is an award-winning architecture, planning, and interiors design firm with 170+ multi-cultural professionals located throughout the Western United States. We offer more than 45 years of experience building communities where we live and work, driven by the vision of creating places that...
May 30, 2023
/PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today the identification of Prophage and (non-) ORF-Jamphage from the...
May 19, 2023
Donor Relations/Grants Management Job in UK, requiring 5-9 years of experience, from IRC; closing on 5 Jun 2023
May 5, 2023
Donor Relations/Grants Management Job in USA, requiring 3-4 years of experience, from IRC; closing on 1 Sep 2023
April 4, 2023
/PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that iNtRON has demonstrated the effectiveness of P18-BE3CRC using a...
January 26, 2023
/PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that it has completed the efficacy evaluation study of BAL200, a novel...
January 12, 2023
/PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that the Tech Transfer process of SAL200, endolysin-based new...
December 13, 2022
AMSTERDAM, Dec. 13, 2022 /PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug
December 13, 2022
/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...